about
The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer managementInternational association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinomaPulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.The revised lung adenocarcinoma classification-an imaging guideIt is all in the sputum: a case of non-resolving pneumonia.Cigarette smoking associated with lung adenocarcinoma in situ in a large case-control study (SFBALCS).Concordant and Discordant EGFR Mutations in Patients With Multifocal Adenocarcinomas: Implications for EGFR-Targeted Therapy.Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.Pro-tumoural CXCL10/CXCR3-A autocrine loop in invasive mucinous lung adenocarcinoma.Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis.The classification of lung carcinoma: time to change the morphology-based approach?Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.MUC5AC, cytokeratin 20 and HER2 expression and K-RAS mutations within mucinogenic growth in congenital pulmonary airway malformations.
P2860
Q26851443-6ADD0AA5-C807-49ED-A6AD-B4EA52415F58Q28303718-401B8A25-CFDA-4DB3-8E65-B8E590878D54Q34404209-1DFC12AE-3E17-493B-954C-6005D3C8B39AQ34404257-5A30613C-2687-4099-998A-0376B8AC28C6Q34573527-5B0585C9-7744-4983-A3B3-8E57B5311026Q36170207-A07783F3-78A2-448E-AD33-A7701CEFF402Q37175551-2DE40681-3AF7-4EE8-84DC-CD135B998841Q37244584-DFCA0DA3-8EDA-4224-91D5-1235765F68BEQ37483162-CBE6A46F-40CE-4AAC-8DDF-8DF59348C7EEQ37607959-E20B6F73-A4ED-4E4D-9083-91773BFEC99DQ37940013-F9788E4A-EFC1-4977-84B0-8A0184EF29E2Q38694064-579883B5-1BB7-4979-8016-1D702B25DCC8Q42510392-7F8AF592-1265-48B1-BCC5-9B5AF7F305F1Q51698466-467BBFA1-C752-4B76-881E-1284A11D627AQ53160356-3A4595A8-5568-4FCF-A09A-FAD9758A79F9Q54366837-27F05DEA-F563-40BA-A186-684BEA77844AQ54528690-4B991DC1-7FC1-48CA-8FF2-B893051F01DD
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Bronchioloalveolar carcinoma: the case for two diseases
@ast
Bronchioloalveolar carcinoma: the case for two diseases
@en
Bronchioloalveolar carcinoma: the case for two diseases
@nl
type
label
Bronchioloalveolar carcinoma: the case for two diseases
@ast
Bronchioloalveolar carcinoma: the case for two diseases
@en
Bronchioloalveolar carcinoma: the case for two diseases
@nl
prefLabel
Bronchioloalveolar carcinoma: the case for two diseases
@ast
Bronchioloalveolar carcinoma: the case for two diseases
@en
Bronchioloalveolar carcinoma: the case for two diseases
@nl
P2093
P356
P1433
P1476
Bronchioloalveolar carcinoma: the case for two diseases
@en
P2093
David H Garfield
Howard L West
Jacques Cadranel
P356
10.3816/CLC.2008.N.004
P407
P577
2008-01-01T00:00:00Z